Intensive graft-versus-host disease prophylaxis is required after unrelated-donor nonmyeloablative stem cell transplantation.

Loren, A W

Intensive graft-versus-host disease prophylaxis is required after unrelated-donor nonmyeloablative stem cell transplantation. [electronic resource] - Bone marrow transplantation May 2005 - 921-6 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

0268-3369

10.1038/sj.bmt.1704887 doi


Adult
Alemtuzumab
Antibodies, Monoclonal--administration & dosage
Antibodies, Monoclonal, Humanized
Antibodies, Neoplasm--administration & dosage
Antineoplastic Combined Chemotherapy Protocols--administration & dosage
Cyclophosphamide--administration & dosage
Female
Graft vs Host Disease--complications
Hematopoietic Stem Cell Transplantation
Humans
Lymphoproliferative Disorders--complications
Male
Middle Aged
Mycophenolic Acid--administration & dosage
Transplantation Chimera
Transplantation Conditioning--methods
Vidarabine--administration & dosage